Volume 2, Issue 4
Editorialp. 511
Antibiotic dosing: do we dose to cure the individual or do we treat the greater societal needs?
Author(s): Joseph M Blondeau and Glenn S Tillotson
Bulletin Boardp. 517
Bulletin Board: Volume 2 Issue 4
Conference Scenep. 521
From vector toxicity to successful clinical evaluation: highlights of the 2nd annual meeting of the British Society for Gene Therapy
Author(s): Lisa D Cooper, Martin L Read, Karen Doyle, Ann Logan and Ana Maria Gonzalez
Drug Evaluationp. 533
Carbamazepine ER capsules for the treatment of bipolar I disorder
Author(s): Richard H Weisler
Drug Evaluationp. 559
Cilansetron: a novel, high-affinity 5-HT3 receptor antagonist for irritable bowel syndrome with diarrhea predominance
Author(s): Georges Coremans
Drug Evaluationp. 569
Miglustat: substrate reduction therapy for glycosphingolipid storage disorders
Author(s): Robin H Lachmann
Short Reportp. 577
Diagnosis of chronic radiating lower back pain without overt focal neurologic deficits: what is the value of segmental nerve blocks?
Author(s): Andre P Wolff, Gerbrand J Groen and Oliver HG Wilder-Smith
Research Articlep. 587
Outcomes of a multidisciplinary team approach to cardiovascular risk reduction in patients with diabetes mellitus
Author(s): Angela M Taylor, Coleen A McNamara, Anne Hedelt, Cherie Chaney, Mary Lou Perry, Thomas M Miller III, Karen D Tyler and Anthony L McCall
Research Articlep. 597
Risk for new-onset diabetes mellitus after transplantation: implication of advanced age and immunosuppressive therapy
Author(s): Moro O Salifu, Dale Distant, Dhiren M Haria, Mariya Stratilatova, Sheni Meghani, Joon Hong, Nabil Sumrani, Eli Friedman and Mariana S Markell
Research Articlep. 603
Changes in mesenteric blood flow during intracranial hypertension due to acute elevations in intra-abdominal pressure
Author(s): Shmuel Avital, Samuel Szomstein, Oscar E Brasesco, Danny Rosin, Pablo Paolucci, Turab Pishori, Klaus Thaler, Ravindra Mailapur, Laurence Sands, Steven Wexner and Raul J Rosenthal
Research Articlep. 609
Passiflora incarnata in the treatment of attention-deficit hyperactivity disorder in children and adolescents
Author(s): Shahin Akhondzadeh, MR Mohammadi and F Momeni
Research Articlep. 615
Caspofungin versus amphotericin B treatment of Aspergillus fumigatus in kidneys of chronically immunosuppressed infected mice
Author(s): Emily Hickey, George Abruzzo, Joel Bowman, Cameron Douglas, Charles Gill, Paul Liberator, Andrew Misura, Bill Pikounis and Ken Bartizal
Review Articlep. 623
Role of immunologic and inflammatory factors in the development of endometriosis: indications for treatment strategies
Author(s): Attila Mihalyi, Kyama C Mutinda, Peter Simsa, Sophie Debrock, Jason M Mwenda and Thomas M D\'Hooghe
Review Articlep. 641
Pathophysiology and treatment of alveolar-capillary dysfunction in chronic heart failure
Author(s): Marco Guazzi
Review Articlep. 649
Therapy of vascular dementia: perspectives and milestones
Author(s): Rita Moretti, Paola Torre, Rodolfo M. Antonello and Giuseppe Cazzato
Review Articlep. 659
Treatment of early rheumatoid arthritis
Author(s): Karim Raza, Mike Salmon and Christopher D Buckley
Review Articlep. 677
Management and treatment of lithium-induced nephrogenic diabetes insipidus
Author(s): Christopher K FinchÃÂ , Tyson WA Brooks, Peggy Yam and Kristi W Kelley
Appendices
Glossary: Volume2; Issue4
Appendices
Appendices: Volume2; Issue4
Appendices
